ConductScience.org, home

Gene · 2814

GP5: glycoprotein V platelet

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. GP5: glycoprotein V platelet. Genes, record 2814. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2814

On this page

Gene

Symbol
GP5
HGNC
Name
glycoprotein V platelet
HGNC
NCBI Gene ID
2814
NCBI Gene
HGNC ID
HGNC:4443
HGNC
Ensembl
ENSG00000178732
NCBI Gene
Aliases
CD42d, GPV
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P40197Platelet glycoprotein V5600Ensembl, GeneID, HGNC

Source UniProt

Patents51

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1911752P40197Espacenet
EP 4641201 A22025-10-2912468P40197Espacenet
EP 4641202 A22025-10-29674P40197Espacenet
EP 4641203 A22025-10-29398P40197Espacenet
JP 2025529142 A2025-09-041757P40197Espacenet
US 12371689 B22025-07-291757P40197Espacenet
JP 2025517967 A2025-06-12398P40197Espacenet
JP 2025517969 A2025-06-1212468P40197Espacenet
JP 2025517970 A2025-06-1211752P40197Espacenet
KR 1020250017230 A2025-02-04398P40197Espacenet

1 to 10 of 51

See all 51 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants867

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGP5 papersNewest fiscal year
R01GM071940High-Resolution CryoEM Reconstruction of Large Complexes72025
P30CA008748Cancer Center Support Grant52025
P30CA016672Cancer Center Support Grant42025
R01AI094386Genome structure, transcription and packaging of dsRNA viruses42025
T32OD010993Comparative Medicine and Pathology Training42025
P51OD011106Wisconsin National Primate Research Center Support32025
P51OD011133The Southwest National Primate Research Center32025
R01AI080609Mechanisms for sensing and responding to interbacterial antagonism32025
T32HL007149Research Training in Hematology at UNC Chapel Hill32025
U54MD007595The RCMI Center for Cancer and Health Disparities Research32025

1 to 10 of 867Source NIH's project files

See all 867 nih grants

Papers2,970

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
A Lipid Nanoparticle-Formulated GP5-mRNA Vaccine Induces PRRSV-Specific Humoral and Cellular Immune Responses in BALB/c Mice.Vet Sci202642797896PubTator, text miningPubMed
Co-Infection of PRRSV-1 and PRRSV-2 in a Single Sow: Complete Genome Characterization Reveals a Novel CH-1a-Backbone Recombinant with an NADC30-Derived Nsp2 in China.Viruses202642797875PubTator, text miningPubMed
Genetic Diversity, Phylogenetic Lineages, and Antigenic Features of the PRRSV-1 GP5 Gene in China.Microorganisms202642795543PubTator, text miningPubMed
Longitudinal Molecular Epidemiology and Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus in a Large-Scale Swine Production System in Northern China, 2023-2026.Transbound Emerg Dis202642768913PubTator, text miningPubMed
Oxidative stress induces porcine RCAN1-1L to promote mitophagy and enhance PRRSV replication.Dev Comp Immunol202642763026PubTator, text miningPubMed
CRISPR and yeast two-hybrid screens identify CD81 as a proviral host factor for PRRSV.J Virol202642734356PubTator, text miningPubMed
Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins.Vaccine202642727398PubTator, text miningPubMed
Comparative analysis of human papilloma virus detection methods and prognostic significance of transcriptionally active viral load in oropharyngeal squamous cell carcinoma.Oral Oncol202642696859PubTator, text miningPubMed
Development and immunological evaluation of a multi-antigen recombinant adenovirus vaccine candidate against PRRSV and PCV2.BMC Vet Res202642675487PubTator, text miningPubMed
ORF5-based molecular characterization of PRRSV reveals multiple Co-circulating lineages in Vietnam, 2021-2026.Vet J202642612749PubTator, text miningPubMed

1 to 10 of 2,970

See all 2,970 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2814

GET https://conductscience.org/api/genes/v1/2814/patents?page=2